• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GYRUS ACMI, INC. SPIRATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GYRUS ACMI, INC. SPIRATION VALVE Back to Search Results
Model Number UNKNOWN
Device Problem Off-Label Use (1494)
Patient Problems Hypoxia (1918); Ventilator Dependent (2395)
Event Date 06/13/2023
Event Type  Injury  
Event Description
Publication reported case study of a patient with chronic obstructive pulmonary disease (copd) that presented for computed tomography (ct) ¿ guided biopsy of the left upper lobe, with percutaneous needle trajectory hitting the left upper lobe mass and left lower lobe, resulting in the development of pneumothorax to the left lower lobe.A surgical chest tube was placed but failed to re-inflate the lungs with a water seal.The patient was transferred to the author¿s institution for further management.Patient pulmonary function tests were performed and showed low expiratory volume.The patient was determined not to be a good candidate for surgical resection.The patient underwent a video-assisted, thoracoscopic-assisted, mechanical and chemical (doxycycline) pleurodesis and endobronchial ultrasound for the staging of lung cancer.Given the patient¿s failure to respond to conservative therapy using chest tube drainage and pleurodesis, the decision was made to attempt endobronchial valve placement.Five spiration valves (valve sizes and lot numbers not identified) were placed in the left lower lobe (anterior, medial basal, lateral basal, posterior basal, and superior segments).The air leak from the chest tube completely resolved and the patient was extubated.The patient became increasingly hypoxemic and refractory to noninvasive positive-pressure ventilation.The patient was reintubated and recruitment maneuvers were used; however, the patient remained hypoxemic.Repeat bronchoscopy was performed and several mucus plugs were suctioned but failed to improve the oxygen status.Tension pneumothorax was considered, but the patient had bilateral breath sounds and was otherwise hemodynamically stable.One valve was removed from the anterior segment, resulting in marked improvement to oxygenation status with worsening of the air leak observed.The patient was transferred to the intensive care unit and intubated with a chest tube while four valves remained in place.After 24 hours, the air leak worsened, and the remaining four valves were removed.
 
Manufacturer Narrative
Gyrus acmi, inc.Has reviewed the event reported within publication by boulos, racha et al.¿hypoxemia after endobronchial valve deployment for persistent air leak.¿ journal of cardiothoracic and vascular anesthesia, s1053-0770(23)00227-6.3 apr.2023, doi:10.1053/j.Jvca.2023.03.036.No device malfunction was reported associated with the patient reported event of hypoxemia resulting in valve removal.The device model numbers were not specified in the publication, however the spiration valve system intended use for the treatment of air leak specifies that ¿the spiration valve is a device to control prolonged air leaks of the lung, or significant air leaks that are likely to become air leaks following lobectomy, segmentectomy, or lung volume reduction surgery.¿ use of the spiration valve for the treatment of air leak as described in the publication is an off-label use of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIRATION VALVE
Type of Device
SPIRATION VALVE
Manufacturer (Section D)
GYRUS ACMI, INC.
6675 185th ave ne
redmond WA 98052
Manufacturer (Section G)
GYRUS ACMI, INC.
6675 185th ave ne
redmond WA 98052
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17313407
MDR Text Key319097007
Report Number3004450998-2023-00044
Device Sequence Number1
Product Code OAZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H060002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Lot NumberUNKNOWN (LITERATURE)
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age64 YR
Patient SexMale
Patient Weight69 KG
-
-